Showing results (1-10 of 9) with videos related to
Sort By:
Pageof 1
Onkologie|February 1, 1985
[High-dose cytosine arabinoside in the treatment of recurrent or acute refractory myeloid leukemias]O Brudler, G Heil, E KurrleMMW Fortschritte Der Medizin|November 9, 2004
[Medical treatment of cancer in the elderly]M Bangerter, B Heinrich, O BrudlerJournal of Immunological Methods|May 20, 1987
Lymphocyte activation by phytohaemagglutinin and pokeweed mitogen. Identification of proliferating cells by monoclonal antibodiesS Serke, M Serke, O BrudlerJournal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 1, 1985
Functional asplenia in malignant mastocytosisJ Roth, O Brudler, E HenzeJournal of Immunology (Baltimore, Md. : 1950)|October 1, 1985
In vitro maturation of B cells in chronic lymphocytic leukemia. I. Synergistic action of phorbol ester and interleukin 2 in the induction of Tac antigen expression and interleukin 2 responsiveness in leukemic B cellsD Kabelitz, K Pfeffer, D von Steldern, et al.Clinical Oncology (Royal College of Radiologists (Great Britain))|December 24, 2005
High efficacy of gemcitabine and cisplatin plus trastuzumab in patients with HER2-overexpressing metastatic breast cancer: a phase II studyH J Stemmler, S Kahlert, O Brudler, et al.Blut|March 1, 1986
Deficient IFN alpha production in hairy cell leukemiaF Porzsolt, R Janik, G Heil, et al.Oncology|April 6, 2005
High efficacy and low toxicity of weekly docetaxel given as first-line treatment for metastatic breast cancerJ Stemmler, W Mair, M Stauch, et al.British Journal of Cancer|March 17, 2011
Randomised phase II trial of gemcitabine plus vinorelbine vs gemcitabine plus cisplatin vs gemcitabine plus capecitabine in patients with pretreated metastatic breast cancerH J Stemmler, D diGioia, W Freier, et al.Pageof 1